Lateralization of opioid receptors in turtle visual cortex.
The opioid mu-agonist morphine, the delta-agonist [D-Ala2,D-Leu5]enkephalin (DADL) and the kappa-agonist bremazocine locally applied to the surface of turtle visual cortex inhibited the orthodromic evoked potential (EP; fast negative component N1). After application of the sigma-agonist SKF 10.047 the inhibition was followed by facilitation of EP. The lack of cross-desensitization to the inhibitory action of opioids upon EP indicates that the drugs exert their effects via different opioid receptors. Bremazocine and morphine predominantly inhibited the left cortical EP, whereas DADL was a potent inhibitor of the right cortical EP. Thus, the opioid receptors which modulate evoked electrical activity of the left visual cortex (LVC) apparently belong mostly to the kappa- and mu-type, while delta-receptors were predominantly responsible for the modulation of electrical activity in the right visual cortex (RVC). Besides, we have studied in vivo binding of the kappa-agonist [3H]ethylketocyclazocine ([3H]EKC) and the delta-agonist [3H]DADL to LVC and RVC. The binding was specific and could be accounted for by the interaction with membrane opioid receptors and/or specific uptake of these drugs by cortex cells. [3H]EKC and [3H]DADL exhibited a more effective binding to LVC and RVC membranes, respectively. The results obtained in vitro apparently indicate that LVC and RVC differ in the number of kappa- and delta-binding sites. Thus, turtle brain may have a side-specific mechanism for selective neurochemical regulation of neuron activity in LVC and RVC realized predominantly via kappa- and delta-receptors, respectively.
Bakalkin GYa
U.S.S.R. Cardiology Research Center, Academy of Medical Sciences, Moscow.
Pivovarov
A S
AS
Kobylyansky
A G
AG
Nesterenko
P N
PN
Yarygin
K N
KN
D000818:Animals; D001575:Benzomorphans / Q000494:pharmacology; D004743:Enkephalin, Leucine / Q000031:analogs & derivatives / Q000494:pharmacology; D016308:Enkephalin, Leucine-2-Alanine; D004745:Enkephalins / Q000378:metabolism; D005074:Evoked Potentials, Visual / Q000187:drug effects; D007839:Functional Laterality / Q000502:physiology*; D009020:Morphine / Q000494:pharmacology; D009270:Naloxone / Q000494:pharmacology; D011957:Receptors, Opioid / Q000378:metabolism* / Q000502:physiology; D014426:Turtles / Q000378:metabolism* / Q000502:physiology; D014793:Visual Cortex / Q000378:metabolism* / Q000502:physiology
D001575:Benzomorphans; D004745:Enkephalins; D011957:Receptors, Opioid; D009270:Naloxone; D004743:Enkephalin, Leucine; D016308:Enkephalin, Leucine-2-Alanine; D009020:Morphine; C027248:bremazocine